Clinical Trial Update: A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intensive chemotherapy with or without glasdegib or azacitidine with or without glasdegib in patients with previously untreated acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Glasdegib (glasdegib)

Snippet

Sponsor: Pfizer | Conditions: Leukemia, Myeloid, Acute | Phase 3 | Status: COMPLETED | Results posted: 2021-06-25